
ARKO Petroleum Upsizes IPO to $18 Amid Strong Demand
ARKO Petroleum successfully priced its IPO at $18 per share, raising $200 million and highlighting its robust distribution network. The company aims for a Nasdaq listing under symbol APC.


Generate Biomedicines, an AI-driven biotech firm focused on asthma treatment, has successfully set its IPO price at $16. This funding will enhance its innovative research in immunology and oncology.

ARKO Petroleum successfully priced its IPO at $18 per share, raising $200 million and highlighting its robust distribution network. The company aims for a Nasdaq listing under symbol APC.
Enphase Energy's financial results for Q4 2025 reflect a revenue dip but strong demand for solar products. The company's strategies and market dynamics were highlighted by CEO Badri Kothandaraman.

Goldman Sachs announced its financial results for 2025, boasting significant revenue and earnings performance. CEO David Solomon emphasized a strategy for growth and capital deployment in 2026.

The US equity market remains strong despite rising geopolitical tensions and new policies. Analysts predict growth driven by underlying economic factors.

Goldman Sachs' 2026 Economic and Financial Market Outlook emphasizes the continued resilience of the US economy amid various challenges. Despite market tumult in 2025, the financial giant remains optimistic about US equities.

Mercury Personal has officially removed its waitlist, granting all users access to an innovative banking platform with enhanced features, including joint accounts and integrated investing options.

Resistant AI raises $25 million in Series B funding led by DTCP to enhance its AI-driven fraud detection solutions. The investment aims to expand its offerings globally.

General Motors released its financial results for Q4 2024, highlighting a net income loss due to significant restructuring charges. The company projects strong financial performance for 2025 amid ongoing industry challenges.

Goldman Sachs has announced its earnings for the fourth quarter and full year of 2024, showcasing robust revenue and net income growth, significantly exceeding prior year figures.

On March 3, 2026, major market trends indicate a high risk in trading CFDs and forex. Market participants must weigh the complexities of these instruments carefully.

On March 10, 2026, the financial landscape shows significant risks for retail investors, especially in complex instruments like CFDs and forex. Analyzing market trends reveals a high level of volatility and investment caution.